Condition
Neuroendocrine Carcinomas (NEC) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Neuroendocrine Carcinomas (NEC) clinical trials that are recruiting, at sites in 2 countries (most in South Korea (1), United States (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Tarlatamab for advanced extrapulmonary neuroendocrine carcinoma
This study will test tarlatamab to see if it can shrink tumors and control disease in adults with relapsed extrapulmonary neuroendocrine carcinoma after prior platinum-based chemotherapy.
-
Testing Peluntamig for Neuroendocrine Carcinomas
This study is testing a new drug called Peluntamig to see if it can safely help people with different types of neuroendocrine cancers, either on its own or with chemotherapy.
Related topics
Quick answers
How many Neuroendocrine Carcinomas (NEC) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in South Korea (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.